Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Drug Interaction Study of Cyclosporine and LY3502970 in Healthy Participants
Sponsor: Eli Lilly and Company
Summary
The main purpose of this study is to determine the levels of study drug called LY3502970 in the blood stream when administered alone and in combination with cyclosporine in healthy participants. The study will also evaluate the safety and tolerability of LY3502970 in healthy participants. This study will last up to approximately 76 days for each participant.
Official title: A Phase 1, Open-Label, Drug Interaction Study to Investigate the Effect of Multiple Doses of Cyclosporine on the Pharmacokinetics of LY3502970 in Healthy Participants
Key Details
Gender
All
Age Range
21 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
32
Start Date
2022-10-17
Completion Date
2023-01-17
Last Updated
2026-05-26
Healthy Volunteers
Yes
Conditions
Interventions
Midazolam
Administered orally.
LY3502970
Administered orally.
Cyclosporine
Administered orally.
Locations (1)
Lilly Centre for Clinical Pharmacology
Singapore, Singapore